Research and Markets has announced the addition of the "Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets" report to their offering.
The global market for gastrointestinal disorder therapeutics and diagnostics reached $49.6 billion in 2015. This market is expected to grow from nearly $51.8 billion in 2016 to $63.8 billion in 2021 at a compound annual growth rate of 4.3% from 2016-2021.
The report provides a brief overview of the gastrointestinal system, which provides an introduction to the disorders of the gastrointestinal system; cites risk factors, where applicable; presents current pharmaceutical treatments, market size and key market participants (both prescription and OTC); and presents potential treatments in R&D, potential market size and future market entrants.
Scope of the Report:
Key Topics Covered:
1: Introduction - Complimentary
2: Executive Summary
5: Prescription Therapy Market
6: OTC Therapy Market
7: Diagnostics And Devices Market
8: Gastrointestinal Product Pipeline
10: Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/l5lhfx/gastrointestinal.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161006006265/en/Business Wire
Last updated on: 06/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.